OraSure Technologies | OSUR - Current Liabilities


OraSure Technologies reported $25.12M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Agilent USD 2.29B 20M Jun/2026
AngioDynamics USD 71.96M 3.68M Sep/2025
Becton, Dickinson and Co. USD 9.54B 139M Sep/2026
Bio Techne USD 163.7M 10.42M Jun/2026
Bio-Rad Laboratories USD 969.1M 7.8M Sep/2026
Bruker USD 1.17B 32.6M Sep/2026
Cerus USD 100.8M 12.37M Dec/2025
Charles River Laboratories USD 1.09B 45.49M Sep/2026
Danaher USD 9.05B 945M Sep/2026
Dentsply International USD 1.22B 32M Sep/2026
Dexcom USD 2.25B 105.1M Sep/2026
Illumina USD 1.16B 422M Sep/2026
Integra LifeSciences USD 329M 1.88M Sep/2026
Intuitive Surgical USD 3.23B 652.4M Sep/2026
IQVIA Holdings USD 7.78B 1.04B Sep/2026
Mesa Laboratories USD 54.4M 6.1M Dec/2025
Mettler Toledo International USD 1.25B 49.81M Sep/2026
Myriad Genetics USD 130.7M 500K Jun/2026
OraSure Technologies USD 25.12M 18.96M Jun/2026
Quidel USD 1.07B 73.7M Sep/2026
Repligen USD 125.69M 6.97M Sep/2026
Revvity USD 701.48M 574.88M Sep/2026
STAAR Surgical USD 75.54M 2.15M Sep/2026
Thermo Fisher Scientific USD 14.17B 899M Sep/2026
Trinity Biotech USD 143.68M 2.48M Mar/2026
Waters USD 2.4B 126M Jun/2026